Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFeedback Regulatory News (FDBK)

Share Price Information for Feedback (FDBK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 82.50
Bid: 80.00
Ask: 85.00
Change: -7.50 (-8.33%)
Spread: 5.00 (6.25%)
Open: 90.00
High: 90.00
Low: 82.50
Prev. Close: 90.00
FDBK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Annual General Meeting - Amendment

6 Nov 2020 15:03

RNS Number : 5643E
Feedback PLC
06 November 2020
 

 

The following amendments have been made to the 'Result of Annual General Meeting' announcement released on 5 November 2020 at 1.23 pm under RNS No 4187E.

 

The 'Total Votes Cast' column in the table below has been updated to show the correct figures. All other details remain unchanged. The full amended text is shown below.

 

Feedback plc

 

Result of Annual General Meeting - Amendment

 

Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the specialist medical imaging technology company, announces that at its annual general meeting held earlier today, all resolutions were duly passed on a poll. The proxy voting results of the resolutions are included below.

 

 

Resolutions

Votes For*

% of votes cast**

Votes Against

% of votes cast**

Votes Withheld**

Total votes cast**

1. To receive and adopt the annual report and accounts for the year ended 31 May 2020

504,134,927

100.00%

-

0.00%

22,000

504,134,927

2. To elect Adam Denning as a director

504,152,622

100.00%

3,305

0.00%

1,000

504,155,927

3. To elect Philipp Prince as a director

479,902,622

95.19%

24,253,305

4.81%

1,000

504,155,927

4. To re-elect Simon Sturge as a director

504,152,486

100.00%

3,441

0.00%

1,000

504,155,927

5. To appoint Price Bailey LLP as auditors of the Company

504,118,963

99.99%

36,964

0.01%

1,000

504,155,927

6. To authorise the directors to allot relevant securities equivalent to up to two thirds of the Company's issued share capital, subject to certain conditions

504,027,372

100.00%

3,305

0.00%

126,250

504,030,677

7. To authorise the directors to allot relevant securities equivalent to up to 10 per cent. of the Company's issued share capital on a non-pre-emptive basis subject to certain conditions

478,945,731

95.01%

25,135,091

4.99%

76,205

504,080,822

 

Notes:

* "Votes For" include votes giving the Chairman discretion.

** "Votes Withheld" are not votes in law and do not count in the number of votes counted for or against a resolution, or towards the total votes cast.

 

-Ends-

Enquiries:

 

Feedback plc

Tom Oakley, CEO

Lindsay Melvin, CFO

+44 (0)1954 718072

IR@fbk.com

Allenby Capital Limited (Nominated Adviser)

David Worlidge / Asha Chotai

+44 (0)20 3328 5656

Peterhouse Capital Limited (Joint Broker)

Lucy Williams / Duncan Vasey

+44 (0)20 7469 0936

Stanford Capital Partners Limited (Joint Broker)

Patrick Claridge / John Howes

+44 20 3815 8880

Walbrook PR Ltd

Tel: 020 7933 8780 or feedbackplc@walbrookpr.com

Paul McManus/Nick Rome/Nicholas Johnson

07980 541 893 or 07748 325 236 or 07884 664 686

 

 

Notes to Editors

 

Feedback plc (AIM: FDBK) is a medical imaging technology business. Its core product, Bleepa, is a revolutionary medical imaging communications app, providing an easy-to-use, high quality tool to enable remote and secure communications between front-line clinicians and teams. Importantly, it is the only CE marked medical imaging communications platform on the NHSx clinical communications tools framework. Bleepa has unparalleled functionality for everyday practice and can be accessed from any internet-connected device, enabling control of patient cases when on the go.

 

Its highly scalable Software as a Service ("SaaS")-based revenue model will provide increasing levels of visibility as the Company grows its customer base. With a growing distribution base and technology in place, the focus is on leveraging key relationships in order to drive sales both in the UK and internationally to all forms of care facilitators. As a fully certified medical device, Bleepa aims to disrupt the medical imaging communications market and, importantly, increase the accuracy and speed of diagnosis.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGGZMGMKVGGGZM
Date   Source Headline
13th Apr 20157:00 amRNSCollaboration with the Oxford Stone Group
27th Feb 20157:00 amRNSAttendance at European Congress of Radiology
13th Feb 20157:00 amRNSHalf Yearly Report
20th Nov 201410:59 amRNSResult of AGM
11th Nov 20141:39 pmRNSTexRAD technology assists in medical trials
30th Oct 20149:16 amRNSPosting of Report & Accounts and Notice of AGM
28th Oct 20147:00 amRNSFinal Results
15th Aug 20142:16 pmRNSDirector/PDMR Shareholding
3rd Jul 201412:17 pmRNSDirector/PDMR Shareholding
30th Jun 20148:00 amRNSDirector/PDMR Shareholding
19th Jun 20142:28 pmRNSChange of Registered Office
16th May 201411:18 amRNSResult of EGM
30th Apr 20149:41 amRNSSchedule 1 - Feedback Plc
30th Apr 20147:01 amRNSAcquisitions Subscription and Admission to Trading
6th Mar 20147:00 amRNSChange of Adviser
19th Feb 20147:00 amRNSHalf Yearly Report
13th Jan 20148:00 amRNSDirectorate Change
20th Dec 20137:00 amRNSHolding(s) in Company
12th Dec 20134:08 pmRNSHolding(s) in Company
12th Dec 20134:07 pmRNSHolding(s) in Company
29th Nov 201312:33 pmRNSResult of AGM
20th Nov 20137:00 amRNSHolding(s) in Company
19th Nov 20137:00 amRNSHolding(s) in Company
12th Nov 20137:01 amRNSHolding(s) in Company
6th Nov 20137:00 amRNSFinal Results
30th Jul 201312:18 pmRNSDisposal of freehold property
29th Jul 201310:46 amRNSResult of General Meeting
11th Jul 20137:00 amRNSDisposal of Freehold Property
3rd Jun 20137:00 amRNSDisposal and Director Change
30th May 201310:50 amRNSResult of General Meeting
14th May 20137:00 amRNSDisposal
13th May 20135:37 pmRNSHolding(s) in Company
19th Mar 20137:00 amRNSAdviser Change of Name
25th Feb 20137:00 amRNSFinal Results
30th Nov 201212:48 pmRNSResult of AGM
12th Nov 20127:00 amRNSDirectorate Change
7th Nov 20127:00 amRNSFinal Results
1st Nov 20127:00 amRNSChange of Registered Office
16th Oct 20127:00 amRNSDirectorate Change
23rd May 20123:58 pmRNSDisposal of Feedback Instruments Limited
11th Apr 20126:27 pmRNSForm 8.3 - Feedback Plc
7th Feb 20127:00 amRNSHalf Yearly Report
24th Nov 20117:00 amRNSDirectors' Shareholding
31st Oct 20116:02 pmRNSTotal Voting Rights
19th Oct 20117:00 amRNSDirector's Shareholding
17th Oct 20117:00 amRNSDirectorate Change
14th Oct 20117:00 amRNSGrant of Options
28th Sep 20117:00 amRNSIssue of Equity
2nd Sep 201111:57 amRNSResult of AGM
29th Jul 20117:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.